Curevac N Vis A Biopharmaceutical Company Based In Ta Bingengermanyfounded In 2000The Company Specializes In Developing Therapies And Vaccines Using Messenger Rnamrnatechnologycurevac Focuses On Prophylactic Vaccinesoncology Treatmentsand Molecular Therapiesutilizing Its Proprietary Mrna Platform To Create Products That Activate At Low Doses And Induce Durable Immune Responses Curevac S Pipeline Includes Vaccines Targeting Infectious Diseases Such As Covid 19Rabiesand Malariaas Well As Mrna Based Cancer Immunotherapies And Treatments For Rare Diseasesthe Company Has Established Strategic Partnerships With Major Pharmaceutical Companies Like Glaxosmithkline And Collaborates With Global Foundations Such As Cepi And The Bill & Melinda Gates Foundation To Enhance Vaccine Accessibility And Researchwith Robust Manufacturing Capabilitiescurevac Is Positioned To Produce Billions Of Vaccine Doses To Support Global Health Initiatives
